nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—Platinum-containing Compounds—Carboplatin—breast cancer	0.325	1	CiPCiCtD
Cisplatin—bone cancer—breast cancer	0.195	1	CtDrD
Cisplatin—ATP7B—breast cancer	0.0465	0.277	CbGaD
Cisplatin—NQO1—breast cancer	0.0248	0.148	CbGaD
Cisplatin—GSTT1—breast cancer	0.0232	0.138	CbGaD
Cisplatin—GSTM1—breast cancer	0.0198	0.118	CbGaD
Cisplatin—GSTP1—breast cancer	0.0184	0.109	CbGaD
Cisplatin—SLC31A2—Carboplatin—breast cancer	0.0183	0.091	CbGbCtD
Cisplatin—GSTP1—Chlorambucil—breast cancer	0.017	0.0846	CbGbCtD
Cisplatin—ATP7B—Carboplatin—breast cancer	0.0132	0.0658	CbGbCtD
Cisplatin—MT1A—Carboplatin—breast cancer	0.0132	0.0658	CbGbCtD
Cisplatin—ATP7A—Carboplatin—breast cancer	0.0132	0.0658	CbGbCtD
Cisplatin—MT2A—Carboplatin—breast cancer	0.0132	0.0658	CbGbCtD
Cisplatin—BCHE—breast cancer	0.0126	0.075	CbGaD
Cisplatin—ABCG2—breast cancer	0.0119	0.0706	CbGaD
Cisplatin—SOD1—Carboplatin—breast cancer	0.0105	0.0522	CbGbCtD
Cisplatin—SLC31A1—Carboplatin—breast cancer	0.0105	0.0522	CbGbCtD
Cisplatin—GSTT1—Carboplatin—breast cancer	0.00878	0.0437	CbGbCtD
Cisplatin—GSTM1—Carboplatin—breast cancer	0.00758	0.0378	CbGbCtD
Cisplatin—NQO1—Carboplatin—breast cancer	0.00602	0.03	CbGbCtD
Cisplatin—PTGS2—breast cancer	0.00581	0.0346	CbGaD
Cisplatin—GSTP1—Carboplatin—breast cancer	0.00548	0.0273	CbGbCtD
Cisplatin—ABCB1—breast cancer	0.00494	0.0294	CbGaD
Cisplatin—ABCC6—Vinblastine—breast cancer	0.0047	0.0234	CbGbCtD
Cisplatin—ABCC5—Fluorouracil—breast cancer	0.00387	0.0193	CbGbCtD
Cisplatin—NQO1—Doxorubicin—breast cancer	0.00345	0.0172	CbGbCtD
Cisplatin—XDH—Carboplatin—breast cancer	0.00315	0.0157	CbGbCtD
Cisplatin—MPO—Carboplatin—breast cancer	0.00315	0.0157	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—breast cancer	0.00289	0.0144	CbGbCtD
Cisplatin—ABCC3—Fluorouracil—breast cancer	0.00244	0.0121	CbGbCtD
Cisplatin—CYP2B6—Thiotepa—breast cancer	0.00217	0.0108	CbGbCtD
Cisplatin—XDH—Doxorubicin—breast cancer	0.0018	0.00898	CbGbCtD
Cisplatin—CYP2C9—Anastrozole—breast cancer	0.00151	0.00752	CbGbCtD
Cisplatin—ABCC2—Tamoxifen—breast cancer	0.0015	0.00748	CbGbCtD
Cisplatin—BCHE—Irinotecan—breast cancer	0.00148	0.00738	CbGbCtD
Cisplatin—CYP2B6—Raloxifene—breast cancer	0.00145	0.0072	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—breast cancer	0.00139	0.00691	CbGbCtD
Cisplatin—ABCG2—Tamoxifen—breast cancer	0.00136	0.00676	CbGbCtD
Cisplatin—ABCC3—Methotrexate—breast cancer	0.00134	0.00669	CbGbCtD
Cisplatin—ABCB1—Toremifene—breast cancer	0.00134	0.00668	CbGbCtD
Cisplatin—ABCG2—Mitoxantrone—breast cancer	0.00132	0.0066	CbGbCtD
Cisplatin—SLC22A2—Vinblastine—breast cancer	0.00126	0.00626	CbGbCtD
Cisplatin—ABCC2—Paclitaxel—breast cancer	0.00117	0.00582	CbGbCtD
Cisplatin—ABCC2—Irinotecan—breast cancer	0.00115	0.00574	CbGbCtD
Cisplatin—CYP2C9—Idarubicin—breast cancer	0.00114	0.0057	CbGbCtD
Cisplatin—ABCC2—Carboplatin—breast cancer	0.0011	0.00548	CbGbCtD
Cisplatin—ABCG2—Paclitaxel—breast cancer	0.00106	0.00526	CbGbCtD
Cisplatin—ABCG2—Irinotecan—breast cancer	0.00104	0.00519	CbGbCtD
Cisplatin—ABCC2—Vinblastine—breast cancer	0.00103	0.00511	CbGbCtD
Cisplatin—ABCG2—Fluorouracil—breast cancer	0.001	0.00498	CbGbCtD
Cisplatin—ABCG2—Carboplatin—breast cancer	0.000995	0.00495	CbGbCtD
Cisplatin—ABCB1—Lapatinib—breast cancer	0.000978	0.00487	CbGbCtD
Cisplatin—CYP2B6—Tamoxifen—breast cancer	0.000955	0.00476	CbGbCtD
Cisplatin—ABCC2—Docetaxel—breast cancer	0.000845	0.00421	CbGbCtD
Cisplatin—ABCG2—Docetaxel—breast cancer	0.000764	0.00381	CbGbCtD
Cisplatin—CYP2B6—Irinotecan—breast cancer	0.000733	0.00365	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—breast cancer	0.00063	0.00314	CbGbCtD
Cisplatin—CYP2C9—Capecitabine—breast cancer	0.000627	0.00312	CbGbCtD
Cisplatin—ABCC2—Methotrexate—breast cancer	0.00061	0.00304	CbGbCtD
Cisplatin—ABCG2—Doxorubicin—breast cancer	0.00057	0.00284	CbGbCtD
Cisplatin—ABCG2—Methotrexate—breast cancer	0.000552	0.00275	CbGbCtD
Cisplatin—ABCB1—Vinorelbine—breast cancer	0.000543	0.0027	CbGbCtD
Cisplatin—CYP2C9—Tamoxifen—breast cancer	0.000505	0.00251	CbGbCtD
Cisplatin—ABCB1—Tamoxifen—breast cancer	0.00049	0.00244	CbGbCtD
Cisplatin—ABCB1—Mitoxantrone—breast cancer	0.000478	0.00238	CbGbCtD
Cisplatin—ABCB1—Gemcitabine—breast cancer	0.000422	0.0021	CbGbCtD
Cisplatin—CYP2B6—Doxorubicin—breast cancer	0.000401	0.002	CbGbCtD
Cisplatin—CYP2C9—Paclitaxel—breast cancer	0.000393	0.00196	CbGbCtD
Cisplatin—ABCB1—Paclitaxel—breast cancer	0.000381	0.0019	CbGbCtD
Cisplatin—ABCB1—Irinotecan—breast cancer	0.000376	0.00187	CbGbCtD
Cisplatin—CYP2C9—Fluorouracil—breast cancer	0.000372	0.00185	CbGbCtD
Cisplatin—SLC31A2—nipple—breast cancer	0.000367	0.0188	CbGeAlD
Cisplatin—ABCB1—Vinblastine—breast cancer	0.000334	0.00166	CbGbCtD
Cisplatin—NQO1—Vincristine—Vinorelbine—breast cancer	0.000327	0.556	CbGdCrCtD
Cisplatin—ATP7A—nipple—breast cancer	0.000324	0.0166	CbGeAlD
Cisplatin—SOD1—nipple—breast cancer	0.000283	0.0145	CbGeAlD
Cisplatin—SLC31A1—nipple—breast cancer	0.000276	0.0142	CbGeAlD
Cisplatin—ABCB1—Docetaxel—breast cancer	0.000276	0.00137	CbGbCtD
Cisplatin—NQO1—Vincristine—Vinblastine—breast cancer	0.000262	0.444	CbGdCrCtD
Cisplatin—MT1A—adipose tissue—breast cancer	0.000244	0.0125	CbGeAlD
Cisplatin—ABCC5—mammary gland—breast cancer	0.000244	0.0125	CbGeAlD
Cisplatin—ATP7B—endometrium—breast cancer	0.000243	0.0124	CbGeAlD
Cisplatin—MT2A—skin of body—breast cancer	0.000239	0.0123	CbGeAlD
Cisplatin—NQO1—mammary gland—breast cancer	0.000228	0.0117	CbGeAlD
Cisplatin—MT1A—female reproductive system—breast cancer	0.000224	0.0115	CbGeAlD
Cisplatin—ATP7B—uterus—breast cancer	0.000224	0.0115	CbGeAlD
Cisplatin—SLC31A2—endometrium—breast cancer	0.000222	0.0114	CbGeAlD
Cisplatin—ATP7B—pituitary gland—breast cancer	0.00022	0.0113	CbGeAlD
Cisplatin—MT1A—adrenal gland—breast cancer	0.000219	0.0112	CbGeAlD
Cisplatin—ATP7B—adipose tissue—breast cancer	0.000219	0.0112	CbGeAlD
Cisplatin—ATP7A—epithelium—breast cancer	0.000218	0.0112	CbGeAlD
Cisplatin—ABCB1—Doxorubicin—breast cancer	0.000205	0.00102	CbGbCtD
Cisplatin—MT2A—adipose tissue—breast cancer	0.000203	0.0104	CbGeAlD
Cisplatin—ATP7B—female reproductive system—breast cancer	0.000201	0.0103	CbGeAlD
Cisplatin—SLC31A2—pituitary gland—breast cancer	0.000201	0.0103	CbGeAlD
Cisplatin—SLC31A2—adipose tissue—breast cancer	0.0002	0.0102	CbGeAlD
Cisplatin—ABCB1—Methotrexate—breast cancer	0.000199	0.000991	CbGbCtD
Cisplatin—ATP7A—endometrium—breast cancer	0.000195	0.01	CbGeAlD
Cisplatin—MT1A—endocrine gland—breast cancer	0.00019	0.00974	CbGeAlD
Cisplatin—NQO1—nipple—breast cancer	0.000189	0.00968	CbGeAlD
Cisplatin—MT2A—female reproductive system—breast cancer	0.000187	0.00958	CbGeAlD
Cisplatin—SLC31A2—female reproductive system—breast cancer	0.000184	0.00942	CbGeAlD
Cisplatin—ATP7B—female gonad—breast cancer	0.000183	0.00938	CbGeAlD
Cisplatin—GSTT1—female reproductive system—breast cancer	0.000183	0.00938	CbGeAlD
Cisplatin—MT2A—adrenal gland—breast cancer	0.000182	0.00935	CbGeAlD
Cisplatin—SLC31A2—adrenal gland—breast cancer	0.000179	0.00919	CbGeAlD
Cisplatin—ATP7A—pituitary gland—breast cancer	0.000177	0.00906	CbGeAlD
Cisplatin—ATP7A—adipose tissue—breast cancer	0.000176	0.00903	CbGeAlD
Cisplatin—CYP4A11—endocrine gland—breast cancer	0.000175	0.00897	CbGeAlD
Cisplatin—SLC31A2—bone marrow—breast cancer	0.000173	0.00889	CbGeAlD
Cisplatin—GSTM1—skin of body—breast cancer	0.000172	0.00884	CbGeAlD
Cisplatin—SOD1—endometrium—breast cancer	0.000171	0.00877	CbGeAlD
Cisplatin—ATP7B—endocrine gland—breast cancer	0.00017	0.00872	CbGeAlD
Cisplatin—MT2A—female gonad—breast cancer	0.00017	0.00872	CbGeAlD
Cisplatin—GSTP1—nipple—breast cancer	0.000169	0.00865	CbGeAlD
Cisplatin—SLC31A2—female gonad—breast cancer	0.000167	0.00857	CbGeAlD
Cisplatin—SLC31A1—endometrium—breast cancer	0.000167	0.00854	CbGeAlD
Cisplatin—XDH—endometrium—breast cancer	0.000165	0.00844	CbGeAlD
Cisplatin—ABCC6—adipose tissue—breast cancer	0.000162	0.00828	CbGeAlD
Cisplatin—MT2A—endocrine gland—breast cancer	0.000158	0.00811	CbGeAlD
Cisplatin—ATP7A—adrenal gland—breast cancer	0.000158	0.0081	CbGeAlD
Cisplatin—SOD1—uterus—breast cancer	0.000158	0.00808	CbGeAlD
Cisplatin—GSTT1—endocrine gland—breast cancer	0.000155	0.00794	CbGeAlD
Cisplatin—SOD1—pituitary gland—breast cancer	0.000155	0.00793	CbGeAlD
Cisplatin—SOD1—adipose tissue—breast cancer	0.000154	0.0079	CbGeAlD
Cisplatin—ATP7A—bone marrow—breast cancer	0.000153	0.00783	CbGeAlD
Cisplatin—SLC31A1—pituitary gland—breast cancer	0.000151	0.00773	CbGeAlD
Cisplatin—SLC31A1—adipose tissue—breast cancer	0.00015	0.0077	CbGeAlD
Cisplatin—ATP7A—female gonad—breast cancer	0.000147	0.00755	CbGeAlD
Cisplatin—GSTM1—adipose tissue—breast cancer	0.000147	0.00752	CbGeAlD
Cisplatin—GSTP1—embryo—breast cancer	0.000139	0.00714	CbGeAlD
Cisplatin—SOD1—adrenal gland—breast cancer	0.000138	0.00709	CbGeAlD
Cisplatin—SLC31A1—female reproductive system—breast cancer	0.000138	0.00708	CbGeAlD
Cisplatin—ATP7A—endocrine gland—breast cancer	0.000137	0.00702	CbGeAlD
Cisplatin—XDH—female reproductive system—breast cancer	0.000136	0.00699	CbGeAlD
Cisplatin—GSTM1—female reproductive system—breast cancer	0.000135	0.00691	CbGeAlD
Cisplatin—SLC31A1—adrenal gland—breast cancer	0.000135	0.00691	CbGeAlD
Cisplatin—SOD1—bone marrow—breast cancer	0.000134	0.00686	CbGeAlD
Cisplatin—GSTM1—adrenal gland—breast cancer	0.000131	0.00674	CbGeAlD
Cisplatin—MT1A—lymph node—breast cancer	0.000131	0.00673	CbGeAlD
Cisplatin—SLC31A1—bone marrow—breast cancer	0.00013	0.00668	CbGeAlD
Cisplatin—SOD1—female gonad—breast cancer	0.000129	0.00661	CbGeAlD
Cisplatin—NQO1—epithelium—breast cancer	0.000127	0.00652	CbGeAlD
Cisplatin—ABCC6—endocrine gland—breast cancer	0.000126	0.00644	CbGeAlD
Cisplatin—SLC31A1—female gonad—breast cancer	0.000126	0.00644	CbGeAlD
Cisplatin—GSTM1—female gonad—breast cancer	0.000123	0.00629	CbGeAlD
Cisplatin—NQO1—skin of body—breast cancer	0.000121	0.0062	CbGeAlD
Cisplatin—ATP7B—lymph node—breast cancer	0.000118	0.00603	CbGeAlD
Cisplatin—MPO—epithelium—breast cancer	0.000117	0.00599	CbGeAlD
Cisplatin—SLC31A1—endocrine gland—breast cancer	0.000117	0.00599	CbGeAlD
Cisplatin—XDH—endocrine gland—breast cancer	0.000115	0.00592	CbGeAlD
Cisplatin—GSTM1—endocrine gland—breast cancer	0.000114	0.00585	CbGeAlD
Cisplatin—NQO1—endometrium—breast cancer	0.000114	0.00584	CbGeAlD
Cisplatin—GSTP1—epithelium—breast cancer	0.000114	0.00582	CbGeAlD
Cisplatin—MPO—skin of body—breast cancer	0.000111	0.0057	CbGeAlD
Cisplatin—ABCC5—pituitary gland—breast cancer	0.00011	0.00565	CbGeAlD
Cisplatin—ABCC5—adipose tissue—breast cancer	0.00011	0.00563	CbGeAlD
Cisplatin—CYP2C9—mammary gland—breast cancer	0.000109	0.00559	CbGeAlD
Cisplatin—GSTP1—skin of body—breast cancer	0.000108	0.00554	CbGeAlD
Cisplatin—SLC31A2—lymph node—breast cancer	0.000107	0.00551	CbGeAlD
Cisplatin—NQO1—uterus—breast cancer	0.000105	0.00539	CbGeAlD
Cisplatin—NQO1—pituitary gland—breast cancer	0.000103	0.00529	CbGeAlD
Cisplatin—NQO1—adipose tissue—breast cancer	0.000103	0.00527	CbGeAlD
Cisplatin—BCHE—nipple—breast cancer	0.000102	0.00524	CbGeAlD
Cisplatin—GSTP1—endometrium—breast cancer	0.000102	0.00522	CbGeAlD
Cisplatin—ABCC5—adrenal gland—breast cancer	9.85e-05	0.00505	CbGeAlD
Cisplatin—ABCC5—bone marrow—breast cancer	9.53e-05	0.00489	CbGeAlD
Cisplatin—MPO—pituitary gland—breast cancer	9.48e-05	0.00486	CbGeAlD
Cisplatin—ATP7A—lymph node—breast cancer	9.47e-05	0.00485	CbGeAlD
Cisplatin—NQO1—female reproductive system—breast cancer	9.44e-05	0.00484	CbGeAlD
Cisplatin—GSTP1—uterus—breast cancer	9.39e-05	0.00481	CbGeAlD
Cisplatin—ABCC3—adipose tissue—breast cancer	9.22e-05	0.00473	CbGeAlD
Cisplatin—GSTP1—pituitary gland—breast cancer	9.22e-05	0.00473	CbGeAlD
Cisplatin—NQO1—adrenal gland—breast cancer	9.22e-05	0.00473	CbGeAlD
Cisplatin—ABCC5—female gonad—breast cancer	9.18e-05	0.00471	CbGeAlD
Cisplatin—GSTP1—adipose tissue—breast cancer	9.18e-05	0.00471	CbGeAlD
Cisplatin—NQO1—female gonad—breast cancer	8.59e-05	0.00441	CbGeAlD
Cisplatin—ABCC3—female reproductive system—breast cancer	8.47e-05	0.00435	CbGeAlD
Cisplatin—MPO—adrenal gland—breast cancer	8.47e-05	0.00434	CbGeAlD
Cisplatin—GSTP1—female reproductive system—breast cancer	8.44e-05	0.00433	CbGeAlD
Cisplatin—SOD1—lymph node—breast cancer	8.29e-05	0.00425	CbGeAlD
Cisplatin—ABCC3—adrenal gland—breast cancer	8.27e-05	0.00424	CbGeAlD
Cisplatin—GSTP1—adrenal gland—breast cancer	8.24e-05	0.00422	CbGeAlD
Cisplatin—MPO—bone marrow—breast cancer	8.2e-05	0.0042	CbGeAlD
Cisplatin—SLC31A1—lymph node—breast cancer	8.07e-05	0.00414	CbGeAlD
Cisplatin—NQO1—endocrine gland—breast cancer	7.99e-05	0.0041	CbGeAlD
Cisplatin—GSTP1—bone marrow—breast cancer	7.97e-05	0.00408	CbGeAlD
Cisplatin—GSTM1—lymph node—breast cancer	7.88e-05	0.00404	CbGeAlD
Cisplatin—ABCC3—female gonad—breast cancer	7.71e-05	0.00395	CbGeAlD
Cisplatin—GSTP1—female gonad—breast cancer	7.68e-05	0.00394	CbGeAlD
Cisplatin—MPO—endocrine gland—breast cancer	7.35e-05	0.00377	CbGeAlD
Cisplatin—ABCC3—endocrine gland—breast cancer	7.17e-05	0.00368	CbGeAlD
Cisplatin—GSTP1—endocrine gland—breast cancer	7.14e-05	0.00366	CbGeAlD
Cisplatin—ABCC2—female reproductive system—breast cancer	6.77e-05	0.00347	CbGeAlD
Cisplatin—ABCC2—adrenal gland—breast cancer	6.61e-05	0.00339	CbGeAlD
Cisplatin—BCHE—skin of body—breast cancer	6.54e-05	0.00335	CbGeAlD
Cisplatin—PTGS2—embryo—breast cancer	6.49e-05	0.00333	CbGeAlD
Cisplatin—BCHE—endometrium—breast cancer	6.17e-05	0.00316	CbGeAlD
Cisplatin—ABCG2—endometrium—breast cancer	5.96e-05	0.00306	CbGeAlD
Cisplatin—ABCC5—lymph node—breast cancer	5.9e-05	0.00303	CbGeAlD
Cisplatin—CYP2B6—skin of body—breast cancer	5.83e-05	0.00299	CbGeAlD
Cisplatin—ABCC2—endocrine gland—breast cancer	5.73e-05	0.00294	CbGeAlD
Cisplatin—BCHE—uterus—breast cancer	5.68e-05	0.00291	CbGeAlD
Cisplatin—BCHE—pituitary gland—breast cancer	5.58e-05	0.00286	CbGeAlD
Cisplatin—BCHE—adipose tissue—breast cancer	5.56e-05	0.00285	CbGeAlD
Cisplatin—NQO1—lymph node—breast cancer	5.52e-05	0.00283	CbGeAlD
Cisplatin—ABCG2—uterus—breast cancer	5.49e-05	0.00282	CbGeAlD
Cisplatin—ABCG2—pituitary gland—breast cancer	5.39e-05	0.00277	CbGeAlD
Cisplatin—ABCG2—adipose tissue—breast cancer	5.37e-05	0.00275	CbGeAlD
Cisplatin—PTGS2—epithelium—breast cancer	5.3e-05	0.00272	CbGeAlD
Cisplatin—BCHE—female reproductive system—breast cancer	5.11e-05	0.00262	CbGeAlD
Cisplatin—MPO—lymph node—breast cancer	5.08e-05	0.0026	CbGeAlD
Cisplatin—PTGS2—skin of body—breast cancer	5.04e-05	0.00258	CbGeAlD
Cisplatin—BCHE—adrenal gland—breast cancer	4.99e-05	0.00256	CbGeAlD
Cisplatin—ABCC3—lymph node—breast cancer	4.96e-05	0.00254	CbGeAlD
Cisplatin—GSTP1—lymph node—breast cancer	4.94e-05	0.00253	CbGeAlD
Cisplatin—BCHE—bone marrow—breast cancer	4.82e-05	0.00247	CbGeAlD
Cisplatin—ABCG2—adrenal gland—breast cancer	4.82e-05	0.00247	CbGeAlD
Cisplatin—PTGS2—endometrium—breast cancer	4.75e-05	0.00244	CbGeAlD
Cisplatin—ABCG2—bone marrow—breast cancer	4.66e-05	0.00239	CbGeAlD
Cisplatin—CYP2B6—female reproductive system—breast cancer	4.56e-05	0.00234	CbGeAlD
Cisplatin—CYP2C9—female reproductive system—breast cancer	4.51e-05	0.00231	CbGeAlD
Cisplatin—ABCG2—female gonad—breast cancer	4.49e-05	0.0023	CbGeAlD
Cisplatin—CYP2B6—adrenal gland—breast cancer	4.45e-05	0.00228	CbGeAlD
Cisplatin—PTGS2—uterus—breast cancer	4.38e-05	0.00225	CbGeAlD
Cisplatin—BCHE—endocrine gland—breast cancer	4.32e-05	0.00222	CbGeAlD
Cisplatin—PTGS2—pituitary gland—breast cancer	4.3e-05	0.00221	CbGeAlD
Cisplatin—PTGS2—adipose tissue—breast cancer	4.28e-05	0.0022	CbGeAlD
Cisplatin—ABCB1—embryo—breast cancer	4.02e-05	0.00206	CbGeAlD
Cisplatin—ABCC2—lymph node—breast cancer	3.96e-05	0.00203	CbGeAlD
Cisplatin—PTGS2—female reproductive system—breast cancer	3.94e-05	0.00202	CbGeAlD
Cisplatin—CYP2B6—endocrine gland—breast cancer	3.86e-05	0.00198	CbGeAlD
Cisplatin—PTGS2—adrenal gland—breast cancer	3.84e-05	0.00197	CbGeAlD
Cisplatin—CYP2C9—endocrine gland—breast cancer	3.82e-05	0.00196	CbGeAlD
Cisplatin—PTGS2—bone marrow—breast cancer	3.72e-05	0.00191	CbGeAlD
Cisplatin—PTGS2—female gonad—breast cancer	3.58e-05	0.00184	CbGeAlD
Cisplatin—PTGS2—endocrine gland—breast cancer	3.33e-05	0.00171	CbGeAlD
Cisplatin—ABCB1—epithelium—breast cancer	3.28e-05	0.00168	CbGeAlD
Cisplatin—BCHE—lymph node—breast cancer	2.99e-05	0.00153	CbGeAlD
Cisplatin—ABCB1—endometrium—breast cancer	2.94e-05	0.00151	CbGeAlD
Cisplatin—ABCG2—lymph node—breast cancer	2.89e-05	0.00148	CbGeAlD
Cisplatin—ABCB1—uterus—breast cancer	2.71e-05	0.00139	CbGeAlD
Cisplatin—ABCB1—pituitary gland—breast cancer	2.66e-05	0.00136	CbGeAlD
Cisplatin—ABCB1—adipose tissue—breast cancer	2.65e-05	0.00136	CbGeAlD
Cisplatin—ABCB1—female reproductive system—breast cancer	2.44e-05	0.00125	CbGeAlD
Cisplatin—ABCB1—adrenal gland—breast cancer	2.38e-05	0.00122	CbGeAlD
Cisplatin—PTGS2—lymph node—breast cancer	2.3e-05	0.00118	CbGeAlD
Cisplatin—ABCB1—bone marrow—breast cancer	2.3e-05	0.00118	CbGeAlD
Cisplatin—ABCB1—female gonad—breast cancer	2.22e-05	0.00114	CbGeAlD
Cisplatin—ABCB1—endocrine gland—breast cancer	2.06e-05	0.00106	CbGeAlD
Cisplatin—ABCB1—lymph node—breast cancer	1.42e-05	0.00073	CbGeAlD
Cisplatin—Myalgia—Docetaxel—breast cancer	9.47e-06	0.000188	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—breast cancer	9.46e-06	0.000188	CcSEcCtD
Cisplatin—Nausea—Vinorelbine—breast cancer	9.46e-06	0.000188	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—breast cancer	9.44e-06	0.000187	CcSEcCtD
Cisplatin—Asthenia—Mitoxantrone—breast cancer	9.42e-06	0.000187	CcSEcCtD
Cisplatin—Asthenia—Irinotecan—breast cancer	9.42e-06	0.000187	CcSEcCtD
Cisplatin—Neuropathy peripheral—Epirubicin—breast cancer	9.41e-06	0.000187	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	9.4e-06	0.000187	CcSEcCtD
Cisplatin—Stomatitis—Epirubicin—breast cancer	9.36e-06	0.000186	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—breast cancer	9.33e-06	0.000185	CcSEcCtD
Cisplatin—Decreased appetite—Paclitaxel—breast cancer	9.31e-06	0.000185	CcSEcCtD
Cisplatin—Hypersensitivity—Fluorouracil—breast cancer	9.26e-06	0.000184	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Paclitaxel—breast cancer	9.24e-06	0.000183	CcSEcCtD
Cisplatin—Asthenia—Gemcitabine—breast cancer	9.18e-06	0.000182	CcSEcCtD
Cisplatin—Myalgia—Capecitabine—breast cancer	9.17e-06	0.000182	CcSEcCtD
Cisplatin—Pain—Paclitaxel—breast cancer	9.16e-06	0.000182	CcSEcCtD
Cisplatin—Anxiety—Capecitabine—breast cancer	9.13e-06	0.000181	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	9.1e-06	0.000181	CcSEcCtD
Cisplatin—Urinary tract disorder—Methotrexate—breast cancer	9.09e-06	0.00018	CcSEcCtD
Cisplatin—Hepatobiliary disease—Epirubicin—breast cancer	9.08e-06	0.00018	CcSEcCtD
Cisplatin—Anaphylactic shock—Docetaxel—breast cancer	9.08e-06	0.00018	CcSEcCtD
Cisplatin—Oedema—Docetaxel—breast cancer	9.08e-06	0.00018	CcSEcCtD
Cisplatin—Discomfort—Capecitabine—breast cancer	9.06e-06	0.00018	CcSEcCtD
Cisplatin—Nausea—Thiotepa—breast cancer	9.03e-06	0.000179	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—breast cancer	9.03e-06	0.000179	CcSEcCtD
Cisplatin—Infection—Docetaxel—breast cancer	9.02e-06	0.000179	CcSEcCtD
Cisplatin—Diarrhoea—Irinotecan—breast cancer	8.98e-06	0.000178	CcSEcCtD
Cisplatin—Diarrhoea—Mitoxantrone—breast cancer	8.98e-06	0.000178	CcSEcCtD
Cisplatin—Nervous system disorder—Docetaxel—breast cancer	8.9e-06	0.000177	CcSEcCtD
Cisplatin—Thrombocytopenia—Docetaxel—breast cancer	8.89e-06	0.000176	CcSEcCtD
Cisplatin—Visual impairment—Methotrexate—breast cancer	8.87e-06	0.000176	CcSEcCtD
Cisplatin—Tachycardia—Docetaxel—breast cancer	8.86e-06	0.000176	CcSEcCtD
Cisplatin—Feeling abnormal—Paclitaxel—breast cancer	8.82e-06	0.000175	CcSEcCtD
Cisplatin—Skin disorder—Docetaxel—breast cancer	8.82e-06	0.000175	CcSEcCtD
Cisplatin—Oedema—Capecitabine—breast cancer	8.79e-06	0.000174	CcSEcCtD
Cisplatin—Bradycardia—Epirubicin—breast cancer	8.77e-06	0.000174	CcSEcCtD
Cisplatin—Diarrhoea—Gemcitabine—breast cancer	8.75e-06	0.000174	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—breast cancer	8.73e-06	0.000173	CcSEcCtD
Cisplatin—Infection—Capecitabine—breast cancer	8.73e-06	0.000173	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—breast cancer	8.71e-06	0.000173	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—breast cancer	8.66e-06	0.000172	CcSEcCtD
Cisplatin—Anorexia—Docetaxel—breast cancer	8.65e-06	0.000172	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—breast cancer	8.63e-06	0.000171	CcSEcCtD
Cisplatin—Nervous system disorder—Capecitabine—breast cancer	8.62e-06	0.000171	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—breast cancer	8.6e-06	0.000171	CcSEcCtD
Cisplatin—Diarrhoea—Fluorouracil—breast cancer	8.6e-06	0.000171	CcSEcCtD
Cisplatin—Thrombocytopenia—Capecitabine—breast cancer	8.6e-06	0.000171	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—breast cancer	8.58e-06	0.00017	CcSEcCtD
Cisplatin—Tachycardia—Capecitabine—breast cancer	8.58e-06	0.00017	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—breast cancer	8.55e-06	0.00017	CcSEcCtD
Cisplatin—Skin disorder—Capecitabine—breast cancer	8.54e-06	0.000169	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—breast cancer	8.51e-06	0.000169	CcSEcCtD
Cisplatin—Hyperhidrosis—Capecitabine—breast cancer	8.49e-06	0.000169	CcSEcCtD
Cisplatin—Hypotension—Docetaxel—breast cancer	8.48e-06	0.000168	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—breast cancer	8.47e-06	0.000168	CcSEcCtD
Cisplatin—Body temperature increased—Paclitaxel—breast cancer	8.46e-06	0.000168	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—breast cancer	8.45e-06	0.000168	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—breast cancer	8.4e-06	0.000167	CcSEcCtD
Cisplatin—Anorexia—Capecitabine—breast cancer	8.38e-06	0.000166	CcSEcCtD
Cisplatin—Vomiting—Mitoxantrone—breast cancer	8.35e-06	0.000166	CcSEcCtD
Cisplatin—Vomiting—Irinotecan—breast cancer	8.35e-06	0.000166	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—breast cancer	8.32e-06	0.000165	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—breast cancer	8.3e-06	0.000165	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—breast cancer	8.3e-06	0.000165	CcSEcCtD
Cisplatin—Rash—Mitoxantrone—breast cancer	8.28e-06	0.000164	CcSEcCtD
Cisplatin—Rash—Irinotecan—breast cancer	8.28e-06	0.000164	CcSEcCtD
Cisplatin—Dermatitis—Irinotecan—breast cancer	8.27e-06	0.000164	CcSEcCtD
Cisplatin—Dermatitis—Mitoxantrone—breast cancer	8.27e-06	0.000164	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Docetaxel—breast cancer	8.27e-06	0.000164	CcSEcCtD
Cisplatin—Hypotension—Capecitabine—breast cancer	8.21e-06	0.000163	CcSEcCtD
Cisplatin—Paraesthesia—Docetaxel—breast cancer	8.15e-06	0.000162	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—breast cancer	8.14e-06	0.000161	CcSEcCtD
Cisplatin—Vomiting—Gemcitabine—breast cancer	8.13e-06	0.000161	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—breast cancer	8.12e-06	0.000161	CcSEcCtD
Cisplatin—Dyspnoea—Docetaxel—breast cancer	8.09e-06	0.000161	CcSEcCtD
Cisplatin—Rash—Gemcitabine—breast cancer	8.06e-06	0.00016	CcSEcCtD
Cisplatin—Dermatitis—Gemcitabine—breast cancer	8.06e-06	0.00016	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—breast cancer	8.05e-06	0.00016	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—breast cancer	8.03e-06	0.000159	CcSEcCtD
Cisplatin—Malnutrition—Methotrexate—breast cancer	8.02e-06	0.000159	CcSEcCtD
Cisplatin—Erythema—Methotrexate—breast cancer	8.02e-06	0.000159	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Capecitabine—breast cancer	8.01e-06	0.000159	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—breast cancer	8e-06	0.000159	CcSEcCtD
Cisplatin—Flushing—Epirubicin—breast cancer	8e-06	0.000159	CcSEcCtD
Cisplatin—Vomiting—Fluorouracil—breast cancer	8e-06	0.000159	CcSEcCtD
Cisplatin—Rash—Fluorouracil—breast cancer	7.93e-06	0.000157	CcSEcCtD
Cisplatin—Dermatitis—Fluorouracil—breast cancer	7.92e-06	0.000157	CcSEcCtD
Cisplatin—Paraesthesia—Capecitabine—breast cancer	7.89e-06	0.000157	CcSEcCtD
Cisplatin—Decreased appetite—Docetaxel—breast cancer	7.89e-06	0.000157	CcSEcCtD
Cisplatin—Hypersensitivity—Paclitaxel—breast cancer	7.89e-06	0.000157	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—breast cancer	7.87e-06	0.000156	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Docetaxel—breast cancer	7.84e-06	0.000156	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—breast cancer	7.83e-06	0.000155	CcSEcCtD
Cisplatin—Dyspnoea—Capecitabine—breast cancer	7.83e-06	0.000155	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—breast cancer	7.82e-06	0.000155	CcSEcCtD
Cisplatin—Nausea—Irinotecan—breast cancer	7.8e-06	0.000155	CcSEcCtD
Cisplatin—Nausea—Mitoxantrone—breast cancer	7.8e-06	0.000155	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—breast cancer	7.78e-06	0.000154	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—breast cancer	7.77e-06	0.000154	CcSEcCtD
Cisplatin—Pain—Docetaxel—breast cancer	7.76e-06	0.000154	CcSEcCtD
Cisplatin—Arrhythmia—Epirubicin—breast cancer	7.7e-06	0.000153	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—breast cancer	7.68e-06	0.000152	CcSEcCtD
Cisplatin—Asthenia—Paclitaxel—breast cancer	7.68e-06	0.000152	CcSEcCtD
Cisplatin—Decreased appetite—Capecitabine—breast cancer	7.64e-06	0.000152	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—breast cancer	7.61e-06	0.000151	CcSEcCtD
Cisplatin—Nausea—Gemcitabine—breast cancer	7.6e-06	0.000151	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Capecitabine—breast cancer	7.59e-06	0.000151	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—breast cancer	7.55e-06	0.00015	CcSEcCtD
Cisplatin—Pain—Capecitabine—breast cancer	7.51e-06	0.000149	CcSEcCtD
Cisplatin—Erythema—Epirubicin—breast cancer	7.5e-06	0.000149	CcSEcCtD
Cisplatin—Malnutrition—Epirubicin—breast cancer	7.5e-06	0.000149	CcSEcCtD
Cisplatin—Feeling abnormal—Docetaxel—breast cancer	7.48e-06	0.000148	CcSEcCtD
Cisplatin—Nausea—Fluorouracil—breast cancer	7.47e-06	0.000148	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—breast cancer	7.45e-06	0.000148	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—breast cancer	7.44e-06	0.000148	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—breast cancer	7.43e-06	0.000148	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—breast cancer	7.41e-06	0.000147	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—breast cancer	7.4e-06	0.000147	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—breast cancer	7.4e-06	0.000147	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—breast cancer	7.39e-06	0.000147	CcSEcCtD
Cisplatin—Diarrhoea—Paclitaxel—breast cancer	7.33e-06	0.000145	CcSEcCtD
Cisplatin—Feeling abnormal—Capecitabine—breast cancer	7.24e-06	0.000144	CcSEcCtD
Cisplatin—Malaise—Methotrexate—breast cancer	7.23e-06	0.000143	CcSEcCtD
Cisplatin—Muscle spasms—Epirubicin—breast cancer	7.21e-06	0.000143	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—breast cancer	7.2e-06	0.000143	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—breast cancer	7.19e-06	0.000143	CcSEcCtD
Cisplatin—Body temperature increased—Docetaxel—breast cancer	7.17e-06	0.000142	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—breast cancer	7.17e-06	0.000142	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—breast cancer	7.12e-06	0.000141	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—breast cancer	7.07e-06	0.00014	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—breast cancer	7.05e-06	0.00014	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—breast cancer	6.96e-06	0.000138	CcSEcCtD
Cisplatin—Body temperature increased—Capecitabine—breast cancer	6.95e-06	0.000138	CcSEcCtD
Cisplatin—Convulsion—Methotrexate—breast cancer	6.94e-06	0.000138	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—breast cancer	6.94e-06	0.000138	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—breast cancer	6.94e-06	0.000138	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—breast cancer	6.93e-06	0.000138	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—breast cancer	6.84e-06	0.000136	CcSEcCtD
Cisplatin—Myalgia—Methotrexate—breast cancer	6.82e-06	0.000135	CcSEcCtD
Cisplatin—Vomiting—Paclitaxel—breast cancer	6.81e-06	0.000135	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.78e-06	0.000134	CcSEcCtD
Cisplatin—Malaise—Epirubicin—breast cancer	6.76e-06	0.000134	CcSEcCtD
Cisplatin—Rash—Paclitaxel—breast cancer	6.75e-06	0.000134	CcSEcCtD
Cisplatin—Dermatitis—Paclitaxel—breast cancer	6.75e-06	0.000134	CcSEcCtD
Cisplatin—Discomfort—Methotrexate—breast cancer	6.74e-06	0.000134	CcSEcCtD
Cisplatin—Leukopenia—Epirubicin—breast cancer	6.71e-06	0.000133	CcSEcCtD
Cisplatin—Hypersensitivity—Docetaxel—breast cancer	6.69e-06	0.000133	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—breast cancer	6.67e-06	0.000132	CcSEcCtD
Cisplatin—Anaphylactic shock—Methotrexate—breast cancer	6.54e-06	0.00013	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—breast cancer	6.54e-06	0.00013	CcSEcCtD
Cisplatin—Asthenia—Docetaxel—breast cancer	6.51e-06	0.000129	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—breast cancer	6.5e-06	0.000129	CcSEcCtD
Cisplatin—Infection—Methotrexate—breast cancer	6.5e-06	0.000129	CcSEcCtD
Cisplatin—Hypersensitivity—Capecitabine—breast cancer	6.47e-06	0.000128	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—breast cancer	6.44e-06	0.000128	CcSEcCtD
Cisplatin—Nervous system disorder—Methotrexate—breast cancer	6.42e-06	0.000127	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—breast cancer	6.41e-06	0.000127	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—breast cancer	6.4e-06	0.000127	CcSEcCtD
Cisplatin—Myalgia—Epirubicin—breast cancer	6.39e-06	0.000127	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—breast cancer	6.36e-06	0.000126	CcSEcCtD
Cisplatin—Nausea—Paclitaxel—breast cancer	6.36e-06	0.000126	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—breast cancer	6.35e-06	0.000126	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.34e-06	0.000126	CcSEcCtD
Cisplatin—Hyperhidrosis—Methotrexate—breast cancer	6.32e-06	0.000126	CcSEcCtD
Cisplatin—Discomfort—Epirubicin—breast cancer	6.31e-06	0.000125	CcSEcCtD
Cisplatin—Asthenia—Capecitabine—breast cancer	6.3e-06	0.000125	CcSEcCtD
Cisplatin—Malaise—Doxorubicin—breast cancer	6.26e-06	0.000124	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—breast cancer	6.24e-06	0.000124	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—breast cancer	6.21e-06	0.000123	CcSEcCtD
Cisplatin—Diarrhoea—Docetaxel—breast cancer	6.21e-06	0.000123	CcSEcCtD
Cisplatin—Anaphylactic shock—Epirubicin—breast cancer	6.12e-06	0.000121	CcSEcCtD
Cisplatin—Oedema—Epirubicin—breast cancer	6.12e-06	0.000121	CcSEcCtD
Cisplatin—Hypotension—Methotrexate—breast cancer	6.11e-06	0.000121	CcSEcCtD
Cisplatin—Infection—Epirubicin—breast cancer	6.08e-06	0.000121	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—breast cancer	6.01e-06	0.000119	CcSEcCtD
Cisplatin—Diarrhoea—Capecitabine—breast cancer	6.01e-06	0.000119	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—breast cancer	6e-06	0.000119	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—breast cancer	5.99e-06	0.000119	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—breast cancer	5.97e-06	0.000119	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methotrexate—breast cancer	5.96e-06	0.000118	CcSEcCtD
Cisplatin—Skin disorder—Epirubicin—breast cancer	5.95e-06	0.000118	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—breast cancer	5.92e-06	0.000117	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—breast cancer	5.91e-06	0.000117	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—breast cancer	5.89e-06	0.000117	CcSEcCtD
Cisplatin—Paraesthesia—Methotrexate—breast cancer	5.87e-06	0.000117	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.87e-06	0.000116	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—breast cancer	5.84e-06	0.000116	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—breast cancer	5.84e-06	0.000116	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—breast cancer	5.83e-06	0.000116	CcSEcCtD
Cisplatin—Vomiting—Docetaxel—breast cancer	5.77e-06	0.000115	CcSEcCtD
Cisplatin—Rash—Docetaxel—breast cancer	5.72e-06	0.000114	CcSEcCtD
Cisplatin—Hypotension—Epirubicin—breast cancer	5.72e-06	0.000114	CcSEcCtD
Cisplatin—Dermatitis—Docetaxel—breast cancer	5.72e-06	0.000113	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—breast cancer	5.69e-06	0.000113	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—breast cancer	5.66e-06	0.000112	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—breast cancer	5.66e-06	0.000112	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—breast cancer	5.65e-06	0.000112	CcSEcCtD
Cisplatin—Infection—Doxorubicin—breast cancer	5.63e-06	0.000112	CcSEcCtD
Cisplatin—Pain—Methotrexate—breast cancer	5.59e-06	0.000111	CcSEcCtD
Cisplatin—Vomiting—Capecitabine—breast cancer	5.59e-06	0.000111	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Epirubicin—breast cancer	5.58e-06	0.000111	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—breast cancer	5.55e-06	0.00011	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—breast cancer	5.55e-06	0.00011	CcSEcCtD
Cisplatin—Rash—Capecitabine—breast cancer	5.54e-06	0.00011	CcSEcCtD
Cisplatin—Dermatitis—Capecitabine—breast cancer	5.54e-06	0.00011	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—breast cancer	5.53e-06	0.00011	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—breast cancer	5.5e-06	0.000109	CcSEcCtD
Cisplatin—Paraesthesia—Epirubicin—breast cancer	5.5e-06	0.000109	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—breast cancer	5.48e-06	0.000109	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—breast cancer	5.46e-06	0.000108	CcSEcCtD
Cisplatin—Anorexia—Doxorubicin—breast cancer	5.4e-06	0.000107	CcSEcCtD
Cisplatin—Nausea—Docetaxel—breast cancer	5.39e-06	0.000107	CcSEcCtD
Cisplatin—Feeling abnormal—Methotrexate—breast cancer	5.39e-06	0.000107	CcSEcCtD
Cisplatin—Decreased appetite—Epirubicin—breast cancer	5.32e-06	0.000106	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—breast cancer	5.29e-06	0.000105	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Epirubicin—breast cancer	5.29e-06	0.000105	CcSEcCtD
Cisplatin—Pain—Epirubicin—breast cancer	5.23e-06	0.000104	CcSEcCtD
Cisplatin—Nausea—Capecitabine—breast cancer	5.22e-06	0.000104	CcSEcCtD
Cisplatin—Body temperature increased—Methotrexate—breast cancer	5.17e-06	0.000103	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.16e-06	0.000102	CcSEcCtD
Cisplatin—Paraesthesia—Doxorubicin—breast cancer	5.09e-06	0.000101	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—breast cancer	5.05e-06	0.0001	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—breast cancer	5.04e-06	0.0001	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—breast cancer	4.92e-06	9.77e-05	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—breast cancer	4.89e-06	9.71e-05	CcSEcCtD
Cisplatin—Pain—Doxorubicin—breast cancer	4.84e-06	9.61e-05	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—breast cancer	4.84e-06	9.6e-05	CcSEcCtD
Cisplatin—Hypersensitivity—Methotrexate—breast cancer	4.82e-06	9.57e-05	CcSEcCtD
Cisplatin—Asthenia—Methotrexate—breast cancer	4.69e-06	9.31e-05	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—breast cancer	4.67e-06	9.26e-05	CcSEcCtD
Cisplatin—Hypersensitivity—Epirubicin—breast cancer	4.51e-06	8.95e-05	CcSEcCtD
Cisplatin—Body temperature increased—Doxorubicin—breast cancer	4.48e-06	8.89e-05	CcSEcCtD
Cisplatin—Diarrhoea—Methotrexate—breast cancer	4.48e-06	8.88e-05	CcSEcCtD
Cisplatin—Asthenia—Epirubicin—breast cancer	4.39e-06	8.72e-05	CcSEcCtD
Cisplatin—Diarrhoea—Epirubicin—breast cancer	4.19e-06	8.31e-05	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—breast cancer	4.17e-06	8.28e-05	CcSEcCtD
Cisplatin—Vomiting—Methotrexate—breast cancer	4.16e-06	8.25e-05	CcSEcCtD
Cisplatin—Rash—Methotrexate—breast cancer	4.12e-06	8.19e-05	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—breast cancer	4.12e-06	8.18e-05	CcSEcCtD
Cisplatin—Asthenia—Doxorubicin—breast cancer	4.06e-06	8.07e-05	CcSEcCtD
Cisplatin—Vomiting—Epirubicin—breast cancer	3.89e-06	7.73e-05	CcSEcCtD
Cisplatin—Nausea—Methotrexate—breast cancer	3.89e-06	7.71e-05	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—breast cancer	3.88e-06	7.69e-05	CcSEcCtD
Cisplatin—Rash—Epirubicin—breast cancer	3.86e-06	7.66e-05	CcSEcCtD
Cisplatin—Dermatitis—Epirubicin—breast cancer	3.86e-06	7.65e-05	CcSEcCtD
Cisplatin—Nausea—Epirubicin—breast cancer	3.64e-06	7.22e-05	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—breast cancer	3.6e-06	7.15e-05	CcSEcCtD
Cisplatin—Rash—Doxorubicin—breast cancer	3.57e-06	7.09e-05	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—breast cancer	3.57e-06	7.08e-05	CcSEcCtD
Cisplatin—Nausea—Doxorubicin—breast cancer	3.36e-06	6.68e-05	CcSEcCtD
Cisplatin—ABCC3—Metabolism—NOS3—breast cancer	4.74e-07	1.15e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRG1—breast cancer	4.74e-07	1.15e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CPT1A—breast cancer	4.73e-07	1.15e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTR—breast cancer	4.73e-07	1.15e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ABCG2—breast cancer	4.73e-07	1.15e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—H2AFX—breast cancer	4.71e-07	1.14e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—breast cancer	4.7e-07	1.14e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MTHFR—breast cancer	4.69e-07	1.14e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALDOA—breast cancer	4.68e-07	1.14e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HPGDS—breast cancer	4.64e-07	1.13e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NCOA1—breast cancer	4.64e-07	1.13e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MTHFR—breast cancer	4.64e-07	1.13e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HBA1—breast cancer	4.61e-07	1.12e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.58e-07	1.11e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP19A1—breast cancer	4.57e-07	1.11e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—STK11—breast cancer	4.57e-07	1.11e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOA3—breast cancer	4.55e-07	1.1e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERCC2—breast cancer	4.54e-07	1.1e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC2A2—breast cancer	4.51e-07	1.1e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ACHE—breast cancer	4.5e-07	1.09e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTT1—breast cancer	4.5e-07	1.09e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.47e-07	1.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.47e-07	1.08e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—breast cancer	4.45e-07	1.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB3—breast cancer	4.44e-07	1.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGFR2—breast cancer	4.44e-07	1.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—COMT—breast cancer	4.42e-07	1.07e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CPT1A—breast cancer	4.42e-07	1.07e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTR—breast cancer	4.42e-07	1.07e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCG2—breast cancer	4.42e-07	1.07e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTP1—breast cancer	4.4e-07	1.07e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CB—breast cancer	4.38e-07	1.06e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	4.37e-07	1.06e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CG—breast cancer	4.36e-07	1.06e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HMOX1—breast cancer	4.34e-07	1.05e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—breast cancer	4.34e-07	1.05e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HPGDS—breast cancer	4.34e-07	1.05e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ITPR1—breast cancer	4.33e-07	1.05e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CAV1—breast cancer	4.32e-07	1.05e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—breast cancer	4.32e-07	1.05e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—breast cancer	4.32e-07	1.05e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HBA1—breast cancer	4.31e-07	1.05e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CAV1—breast cancer	4.28e-07	1.04e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTHFR—breast cancer	4.27e-07	1.04e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP17A1—breast cancer	4.26e-07	1.03e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—breast cancer	4.26e-07	1.03e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—COMT—breast cancer	4.25e-07	1.03e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTP1—breast cancer	4.23e-07	1.03e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ENO1—breast cancer	4.22e-07	1.02e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS1—breast cancer	4.22e-07	1.02e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—breast cancer	4.21e-07	1.02e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ACHE—breast cancer	4.21e-07	1.02e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTT1—breast cancer	4.21e-07	1.02e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HMOX1—breast cancer	4.17e-07	1.01e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ABCB1—breast cancer	4.17e-07	1.01e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ITPR1—breast cancer	4.16e-07	1.01e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—breast cancer	4.15e-07	1.01e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP2D6—breast cancer	4.14e-07	1e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGFR1—breast cancer	4.13e-07	1e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TYMS—breast cancer	4.09e-07	9.93e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HIF1A—breast cancer	4.07e-07	9.88e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NCOA2—breast cancer	4.06e-07	9.85e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PLA2G4A—breast cancer	4.05e-07	9.81e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTM1—breast cancer	4.05e-07	9.81e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NCOR1—breast cancer	4.05e-07	9.81e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ABCB1—breast cancer	4.01e-07	9.72e-06	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—breast cancer	4e-07	9.7e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP17A1—breast cancer	3.98e-07	9.66e-06	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.95e-07	9.57e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ENO1—breast cancer	3.94e-07	9.56e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS1—breast cancer	3.94e-07	9.56e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CG—breast cancer	3.94e-07	9.56e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—FASN—breast cancer	3.94e-07	9.56e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CAV1—breast cancer	3.94e-07	9.55e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TYMS—breast cancer	3.93e-07	9.54e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.93e-07	9.53e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—BCHE—breast cancer	3.92e-07	9.52e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CG—breast cancer	3.9e-07	9.46e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NCOR1—breast cancer	3.89e-07	9.43e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PLA2G4A—breast cancer	3.89e-07	9.43e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTM1—breast cancer	3.89e-07	9.43e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.88e-07	9.4e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GPX1—breast cancer	3.87e-07	9.4e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC5A5—breast cancer	3.87e-07	9.4e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP2D6—breast cancer	3.87e-07	9.38e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CD—breast cancer	3.84e-07	9.31e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1A1—breast cancer	3.84e-07	9.3e-06	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—breast cancer	3.83e-07	9.28e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ERCC2—breast cancer	3.8e-07	9.23e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOA2—breast cancer	3.79e-07	9.2e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ALB—breast cancer	3.79e-07	9.19e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—breast cancer	3.78e-07	9.18e-06	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—breast cancer	3.78e-07	9.16e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NQO1—breast cancer	3.74e-07	9.08e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC2A1—breast cancer	3.74e-07	9.08e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GPX1—breast cancer	3.72e-07	9.03e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS2—breast cancer	3.7e-07	8.99e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1A1—breast cancer	3.69e-07	8.94e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—FASN—breast cancer	3.68e-07	8.93e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOTCH1—breast cancer	3.67e-07	8.9e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—BCHE—breast cancer	3.66e-07	8.89e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ERCC2—breast cancer	3.66e-07	8.87e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP3A4—breast cancer	3.65e-07	8.85e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NOS3—breast cancer	3.62e-07	8.79e-06	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—breast cancer	3.62e-07	8.78e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC5A5—breast cancer	3.62e-07	8.78e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1B1—breast cancer	3.59e-07	8.7e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APC—breast cancer	3.59e-07	8.7e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KIT—breast cancer	3.59e-07	8.7e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MTHFR—breast cancer	3.58e-07	8.67e-06	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.57e-07	8.66e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGF—breast cancer	3.55e-07	8.6e-06	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—breast cancer	3.53e-07	8.57e-06	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—breast cancer	3.53e-07	8.56e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HSP90AA1—breast cancer	3.52e-07	8.53e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NQO1—breast cancer	3.5e-07	8.48e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC2A1—breast cancer	3.5e-07	8.48e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CD—breast cancer	3.46e-07	8.4e-06	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—breast cancer	3.44e-07	8.34e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MTHFR—breast cancer	3.44e-07	8.34e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CD—breast cancer	3.43e-07	8.31e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.42e-07	8.3e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NCOA1—breast cancer	3.42e-07	8.3e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ALB—breast cancer	3.42e-07	8.29e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP3A4—breast cancer	3.41e-07	8.27e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.39e-07	8.23e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ALB—breast cancer	3.38e-07	8.21e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP19A1—breast cancer	3.37e-07	8.18e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—STK11—breast cancer	3.37e-07	8.18e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BRAF—breast cancer	3.37e-07	8.18e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1B1—breast cancer	3.35e-07	8.13e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CB—breast cancer	3.34e-07	8.11e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—breast cancer	3.31e-07	8.04e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CAV1—breast cancer	3.3e-07	8e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.29e-07	7.97e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT2—breast cancer	3.28e-07	7.96e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NOS3—breast cancer	3.27e-07	7.93e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NOS3—breast cancer	3.24e-07	7.85e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOA1—breast cancer	3.2e-07	7.76e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CAV1—breast cancer	3.17e-07	7.69e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CD—breast cancer	3.15e-07	7.65e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—STK11—breast cancer	3.15e-07	7.64e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP19A1—breast cancer	3.15e-07	7.64e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.15e-07	7.64e-06	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—breast cancer	3.14e-07	7.61e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—COMT—breast cancer	3.14e-07	7.61e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTP1—breast cancer	3.12e-07	7.57e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SERPINE1—breast cancer	3.12e-07	7.57e-06	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—breast cancer	3.08e-07	7.48e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HMOX1—breast cancer	3.08e-07	7.47e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ITPR1—breast cancer	3.07e-07	7.45e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CB—breast cancer	3.02e-07	7.32e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CG—breast cancer	3e-07	7.29e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—breast cancer	2.99e-07	7.25e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CB—breast cancer	2.99e-07	7.25e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS3—breast cancer	2.98e-07	7.22e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—breast cancer	2.96e-07	7.18e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.96e-07	7.18e-06	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—breast cancer	2.96e-07	7.17e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—COMT—breast cancer	2.93e-07	7.11e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTP1—breast cancer	2.92e-07	7.07e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TYMS—breast cancer	2.9e-07	7.04e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—breast cancer	2.89e-07	7.01e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CG—breast cancer	2.89e-07	7e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HMOX1—breast cancer	2.88e-07	6.98e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ITPR1—breast cancer	2.87e-07	6.96e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NCOR1—breast cancer	2.87e-07	6.96e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTM1—breast cancer	2.87e-07	6.96e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PLA2G4A—breast cancer	2.87e-07	6.96e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MDM2—breast cancer	2.83e-07	6.85e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RAF1—breast cancer	2.82e-07	6.83e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—breast cancer	2.79e-07	6.76e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCB1—breast cancer	2.76e-07	6.7e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CB—breast cancer	2.75e-07	6.67e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTOR—breast cancer	2.75e-07	6.67e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GPX1—breast cancer	2.75e-07	6.66e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—breast cancer	2.74e-07	6.66e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1A1—breast cancer	2.72e-07	6.6e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TYMS—breast cancer	2.71e-07	6.58e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ERCC2—breast cancer	2.7e-07	6.54e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTM1—breast cancer	2.68e-07	6.5e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOR1—breast cancer	2.68e-07	6.5e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.68e-07	6.5e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—breast cancer	2.67e-07	6.47e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CD—breast cancer	2.64e-07	6.41e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—breast cancer	2.61e-07	6.33e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALB—breast cancer	2.61e-07	6.32e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—breast cancer	2.58e-07	6.26e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1B—breast cancer	2.58e-07	6.26e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GPX1—breast cancer	2.57e-07	6.22e-06	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—breast cancer	2.56e-07	6.22e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1A1—breast cancer	2.54e-07	6.16e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CD—breast cancer	2.54e-07	6.16e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTHFR—breast cancer	2.53e-07	6.15e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ERCC2—breast cancer	2.52e-07	6.11e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALB—breast cancer	2.51e-07	6.08e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NOS3—breast cancer	2.49e-07	6.05e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CTNNB1—breast cancer	2.44e-07	5.91e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NOS3—breast cancer	2.4e-07	5.81e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1A—breast cancer	2.38e-07	5.78e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—breast cancer	2.38e-07	5.76e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTHFR—breast cancer	2.37e-07	5.74e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CAV1—breast cancer	2.34e-07	5.67e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CB—breast cancer	2.3e-07	5.58e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CB—breast cancer	2.21e-07	5.37e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SRC—breast cancer	2.2e-07	5.34e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—breast cancer	2.19e-07	5.32e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CAV1—breast cancer	2.18e-07	5.3e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—breast cancer	2.18e-07	5.29e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CG—breast cancer	2.13e-07	5.17e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—breast cancer	2.12e-07	5.15e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.09e-07	5.06e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—breast cancer	2.04e-07	4.95e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK3—breast cancer	2.03e-07	4.92e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CG—breast cancer	1.99e-07	4.83e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—breast cancer	1.99e-07	4.83e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—breast cancer	1.97e-07	4.79e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—breast cancer	1.97e-07	4.78e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—breast cancer	1.93e-07	4.68e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—breast cancer	1.91e-07	4.64e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CD—breast cancer	1.87e-07	4.54e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALB—breast cancer	1.85e-07	4.48e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—breast cancer	1.84e-07	4.46e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—breast cancer	1.82e-07	4.42e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—breast cancer	1.82e-07	4.42e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NOS3—breast cancer	1.77e-07	4.29e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CD—breast cancer	1.75e-07	4.24e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALB—breast cancer	1.73e-07	4.19e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—breast cancer	1.68e-07	4.06e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—breast cancer	1.67e-07	4.04e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NOS3—breast cancer	1.65e-07	4.01e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CB—breast cancer	1.63e-07	3.96e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—breast cancer	1.62e-07	3.92e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—breast cancer	1.55e-07	3.76e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CB—breast cancer	1.52e-07	3.7e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—breast cancer	1.51e-07	3.66e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—breast cancer	1.5e-07	3.65e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—breast cancer	1.49e-07	3.61e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—breast cancer	1.48e-07	3.6e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—breast cancer	1.41e-07	3.42e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—breast cancer	1.4e-07	3.4e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—breast cancer	1.37e-07	3.32e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—breast cancer	1.35e-07	3.27e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—breast cancer	1.32e-07	3.2e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—breast cancer	1.15e-07	2.78e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—breast cancer	1.1e-07	2.67e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—breast cancer	9.95e-08	2.41e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—breast cancer	9.29e-08	2.25e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—breast cancer	8.13e-08	1.97e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—breast cancer	7.59e-08	1.84e-06	CbGpPWpGaD
